FDA Inspection 1235890 — Bieffe Medital SpA
The FDA completed an inspection of Bieffe Medital SpA on November 17, 2023 in Sondalo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 17, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sondalo (Italy)
Additional Details
Mutual Recognition Agreement (MRA)